 | Up a level |
2012
Hermine, Olivier, Hoster, Eva, Walewski, Jan, Ribrag, Vincent, Brousse, Nicole, Thieblemont, Catherine 
ORCID: 0000-0002-9941-2448, Bouabdallah, Reda, Dohner, Hartrnut, Feugier, Pierre, Forspointner, Roswitha, Haioun, Corinne, Kneba, Michael, Haenel, Mathias, Casasnovas, Olivier, Mertelsmann, Roland H., Hallek, Michael, Bosly, Andre, Nowacki, M., Klapper, Wolfram, Gisselbrecht, Christian, Coiffier, Bertrand, Unterhalt, Michael, Hiddemann, Wolfgang and Dreyling, Martin H.
(2012).
Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net).
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971